Erratum: High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III (The American Journal of Clinical Nutrition (2014) 99 (320-327) DOI: 10.3945/ajcn.113.073148);High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III1-3

American Journal of Clinical Nutrition

Volumn 99, Issue 2, 2014, Pages 320-327

  Chang, Alex R ^a,b,c   Lazo, Mariana ^b   Appel, Lawrence J ^b,c   Gutiérrez, Orlando M ^c,d   Grams, Morgan E ^b  

^a GEISINGER HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Hopkins University   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS;

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; FEMALE; FOOD QUALITY; HUMAN; MALE; MIDDLE AGED; MORTALITY; PHOSPHATE INTAKE; PROSPECTIVE STUDY; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY INTAKE; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; HEALTH FOOD; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; MORTALITY; MOTOR ACTIVITY; NUTRITION SURVEYS; PHOSPHORUS, DIETARY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; SODIUM, DIETARY; STRESS, PSYCHOLOGICAL; UNITED STATES; YOUNG ADULT;

EID: 84893384309     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.117.154013     Document Type: Erratum

References (46)

1. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Food, Nutrition Board IoM. Dietary Reference Intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: The National Academies Press, 1997.
2. Bijvoet OL. Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate. Clin Sci 1969;37:23-36.
3. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 2011;305:1119-27.
4. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RBS, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007;167:879-85.
5. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G, Cholesterol And Recurrent Events Trial Investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005;112:2627-33.
6. Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (cardiovascular health study). J Am Coll Cardiol 2012;60:200-7.
7. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study. Ann Intern Med 2010;152:640-8.
8. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006;21:1187-96.
9. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006;91:3144-9.
10. Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012;82:737-47.
11. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;121:4393-408.
12. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009;119:2545-52.
13. Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol 2013;24:125-35.
14. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: Programs and collection procedures. Vital Health Stat 1 1994;32:1-407.
15. Stevens PE, Levin A. Kidney disease: Improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158:825-30.
16. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(4 suppl):1220S-8S; discussion 1229S-31S.
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
18. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, Levey AS, Coresh J. Calibration of serum creatinine in the national health and nutrition examination surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 2007;50:918-26.
19. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol 2002;13:1034-9.
20. NHANES III linked mortality file. Atlanta, GA: Centers for Disease Control and Prevention, 2009. Updated September 25. Available from: Http://www.cdc.gov/nchs/data-access/data-linkage/mortality/nhanes3-linkage. htm#analytic (cited 13 August 2012).
21. World Health Organization. International statistical classification of diseases and related health problems. tenth revision. (ICD-10-CM). Geneva, Switzerland: World Health Organization, 1992.
22. Murtaugh MA, Filipowicz R, Baird BC, Wei G, Greene T, Beddhu S. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant 2012;27:990-6.
23. Dominguez JR, Kestenbaum B, Chonchol M, Block G, Laughlin GA, Lewis CE, Katz R, Barrett-Connor E, Cummings S, Orwoll ES, et al. Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: The osteoporotic fractures in men (MrOS) study. Am J Kidney Dis 2013;61:555-63.
24. Palomino HL, Rifkin DE, Anderson C, Criqui MH, Whooley MA, Ix JH. 24-hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol 2013;8:1202-10.
25. Dominguez JR, Shlipak MG, Whooley MA, Ix JH. Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol 2013;24:647-54.
26. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, et al. Sodium, blood pressure, and cardiovascular disease: Further evidence supporting the american heart association sodium reduction recommendations. Circulation 2012;126:2880-9.
27. Portale AA, Halloran BP, Morris RC Jr. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 1987;80:1147-54.
28. de Boer IH, Rue TC, Kestenbaum B. Serum phosphorus concentrations in the third national health and nutrition examination survey (NHANES III). Am J Kidney Dis 2009;53:399-407.
29. Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, et al. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 2006;70:2141-7.
30. Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009;20:1504-12.
31. Lee H, Oh SW, Heo NJ, Chin HJ, Na KY, Kim S, Chae DW. Serum phosphorus as a predictor of low-grade albuminuria in a general population without evidence of chronic kidney disease. Nephrol Dial Transplant 2012;27:2799-806.
32. Tuttle KR, Short RA. Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function. Clin J Am Soc Nephrol 2009;4:1968-73.
33. Chang A, Batch BC, McGuire HL, Vollmer WM, Svetkey LP, Tyson CC, Sanguankeo A, Anderson C, Houston J, Appel LJ. Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: The PREMIER study. Am J Kidney Dis (Epub ahead of print 27 June 2013).
34. Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, Donahue SE, Asplin J. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011;6:257-64.
35. Isakova T, Gutierrez OM, Smith K, Epstein M, Keating LK, Juppner H, Wolf M. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 2011;26:584-91.
36. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE. Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am J Kidney Dis 1996;27:652-63.
37. Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012;23:1407-15.
38. Chang SH, Yu KN, Lee YS, An GH, Beck GR Jr, Colburn NH, Lee KH, Cho MH. Elevated inorganic phosphate stimulates akt-ERK1/2-Mnk1 signaling in human lung cells. Am J Respir Cell Mol Biol 2006; 35:528-39.
39. Jin H, Chang SH, Xu CX, Shin JY, Chung YS, Park SJ, Lee YS, An GH, Lee KH, Cho MH. High dietary inorganic phosphate affects lung through altering protein translation, cell cycle, and angiogenesis in developing mice. Toxicol Sci 2007;100:215-23.
40. Camalier CE, Young MR, Bobe G, Perella CM, Colburn NH, Beck GR Jr. Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis. Cancer Prev Res (Phila) 2010;3:359-70.
41. Brinkman MT, Buntinx F, Kellen E, Dagnelie PC, Van Dongen MC, Muls E, Zeegers MP. Dietary intake of micronutrients and the risk of developing bladder cancer: Results from the belgian case-control study on bladder cancer risk. Cancer Causes Control 2011;22:469-78.
42. Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, Holmberg L, Van Hemelrijck M. Inorganic phosphate and the risk of cancer in the Swedish AMORIS study. BMC Cancer 2013; 13:257.
43. Calvo MS, Uribarri J. Contributions to total phosphorus intake: All sources considered. Semin Dial 2013;26:54-61.
44. Bell RR, Draper HH, Tzeng DY, Shin HK, Schmidt GR. Physiological responses of human adults to foods containing phosphate additives. J Nutr 1977;107:42-50.
45. Karp HJ, Vaihia KP, Karkkainen MU, Niemisto MJ, Lamberg-Allardt CJ. Acute effects of different phosphorus sources on calcium and bone metabolism in young women: A whole-foods approach. Calcif Tissue Int 2007;80:251-8.
46. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: Implications for renal patients. J Ren Nutr 2007;17:350-4. Diseases